Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Stem cells are unspecialized cells that mature into specialized cells which produce different type of tissues in the human body. They are characterized by the capability to renew themselves through mitotic cell division and differentiating into a diverse range of specialized cell types. They play a vital role in development, growth, maintenance, and repair of brain, bones, muscles, nerves, blood, skin, and other organs. Stem cell research holds tremendous potential in the development of novel therapies for many serious diseases and injuries. Stem cell research is being pursued in the hope of accomplishing major medical breakthroughs. Researchers are striving to create therapies that rebuild or replace damaged cells with tissues grown from stem cells and offer hope to people suffering from cancer, diabetes, cardiovascular disease, spinal-cord injuries, and many other disorders. Adult and embryonic stem cells may also offer scientists to develop valuable techniques of drug discovery and testing.
The global stem cells market has gained sustainable growth owing to increasing investments from pharmaceutical companies intended for stem cell research. Snowballing incidence of chronic diseases is another driving factor augmenting the demand of stem cell market. In the future, the stem cell market growth is predicted to boost due to increasing research and development, high-quality stem cell banking services, and growing stem cell donors. Numerous studies have been carried out to evaluate the trend in stem cell culture. These studies are expected to help businesses in bringing possible qualitative and quantitative changes in product line. However, ethical apprehensions coupled with public perception in context to stem cell at different stages of research is projected to hinder the implementation of this therapy up to certain level
Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.
The report analyses the global Stem Cell market based on by product, source, technology, application, end user and geography.
Based on product, the global stem cells market is segmented into adult stem cell, human embryonic stem cell and induced pluripotent stem cell. The adult stem cells are further segmented into neuronal stem cells, hematopoietic stem cells, mesenchymal stem cells, umbilical cord stem cells and others. Amongst all major products, the adult stem cells are projected to grow at high pace, as they could multiply into scores of specialized cells, repair tissue damage and lower the risks of rejection. Promising segments such as induced pluripotent stem cells could also offer satisfying prospects in the market with the help of its unique traits and advantages.
Based on source, the global stem cells market is segmented into autologous and allogeneic sources. The allogenic stem cell segment is expected to grow at the highest rate during the forecast period, owing to wider therapeutic applications of allogeneic stem cells, intensifying commercialization of allogeneic stem cell therapy products, and growing number of clinical trials related to allogeneic stem cell therapies.
Based on technology, this market is segmented by cell acquisition, cell production, cryopreservation and expansion and sub-culture. The cell acquisition technology is further divided into bone marrow harvest, umbilical blood cord and apheresis. Moreover, the cell production technology is segmented into therapeutic cloning, in-vitro fertilization, cell culture and isolation.
Based on application, the stem cell market is divided into regenerative medicine and drug discovery and development applications. Some major diseases covered in the regenerative medicine applications are neurology, orthopaedics, oncology, haematology, cardiovascular and myocardial infraction, injuries, diabetes, liver disorder, incontinence and others.
Based on end user, the stem cell market is categorized into therapeutic companies, cell and tissue banks, tools and reagent companies, and service companies.
By geography, Stem cells market is studied across the countries of key regions such as, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America comprises United States, Canada and Mexico whereas Europe would primarily cover Germany, France, UK, Italy and Rest of Europe. The key countries included under Asia Pacific are China, Japan, India, Australia, and Rest of Asia Pacific. In Latin America, Brazil, Argentina, and Rest of Latin America are the key countries whereas in Middle East & Africa, South Africa and Rest of MEA are the key countries covered in the report. North America is expected to be the fastest-growing region during the prediction period. Factors such as increasing awareness regarding therapeutic potency of stem cells, growing number of clinical trials for stem cell-based products, and public-private funding & research grants are fuelling the growth in North America. Moreover, rise in the number of research and development projects in Japan, Australia, and Singapore, is anticipated to drive progress in APAC region. In the meantime, regulatory changes in regenerative medicine in Japan has fascinated momentous interest in the market, especially due to augmented commercialization opportunities.
Some of the key participants in the stem cells market include Cytori Therapeutics, Inc., Mesoblast Ltd., Astellas Pharma Inc., STEMCELL Technologies Inc., Osiris Therapeutics Inc, Celgene Corporation, BioTime, Inc., Cynata Therapeutics Limited, Human Longevity Inc, Cellular Engineering Technologies Inc., U.S. Stem Cell, Inc. BrainStorm Cell Therapeutics Inc. Caladrius Biosciences, Inc., and Promethera Biosciences. New product launches and endorsements are the key growth strategies adopted by major players to reinforce their positions in the international market. Furthermore, strategies such as expansions, as well as partnerships and agreements were also implemented by numerous market players to expand their R&D competences and geographic presence in the global market.
The report analyses the global Stem Cell market based on by product, source, technology, application, end user and geography. Based on product, the global stem cells market is segmented into adult stem cell, human embryonic stem cell and induced pluripotent stem cell. The adult stem cells are further segmented into neuronal stem cells, hematopoietic stem cells, mesenchymal stem cells, umbilical cord stem cells and others. Based on technology, this market is segmented by cell acquisition, cell production, cryopreservation and expansion and sub-culture. Based on source, the global stem cells market is segmented into autologous and allogeneic sources. Based on application, the stem cell market is divided into regenerative medicine and drug discovery and development applications. Based on end user, the stem cell market is categorized into therapeutic companies, cell and tissue banks, tools and reagent companies, and service companies. By geography, Stem cells market is studied across the countries of key regions such as, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Some of the key participants in the stem cells market include Cytori Therapeutics, Inc., Mesoblast Ltd., Astellas Pharma Inc., STEMCELL Technologies Inc., Osiris Therapeutics Inc, Celgene Corporation, BioTime, Inc., Cynata Therapeutics Limited, Human Longevity Inc, Cellular Engineering Technologies Inc., U.S. Stem Cell, Inc. BrainStorm Cell Therapeutics Inc. Caladrius Biosciences, Inc., and Promethera Biosciences. New product launches and endorsements are the key growth strategies adopted by major players to reinforce their positions in the international market. Furthermore, strategies such as expansions, as well as partnerships and agreements were also implemented by numerous market players to expand their R&D competences and geographic presence in the global market.
Why to buy this report:
